Literature DB >> 22339063

Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis.

Xu Wang1, Wantao Chen.   

Abstract

Gambogic acid (GA) is a caged xanthone that is derived from Garcinia hanburyi and functions as a strong apoptotic inducer in many types of cancer cells. The distinct effectiveness of GA has led to its characterization as a novel anti-cancer agent. There is an increasing number of research studies focused on elucidating the molecular mechanisms of GA-induced anti-cancer effects, and several critical signaling pathways have been reported to be influenced by GA treatment. In this review, we summarize the multiple functional effects of GA administration in cancer cells including the induction of apoptosis, the inhibition of proliferation and the prevention of cancer metastasis and tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22339063     DOI: 10.2174/187152012802650066

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  25 in total

Review 1.  Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics.

Authors:  Elham Hatami; Meena Jaggi; Subhash C Chauhan; Murali M Yallapu
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-05-31       Impact factor: 10.680

2.  Gambogenic acid induces cell growth inhibition, cell cycle arrest and metastasis inhibition in choroidal melanoma in a dose-dependent manner.

Authors:  Fenghua Li; Yansa Wang; Ying Yan
Journal:  Exp Ther Med       Date:  2017-03-22       Impact factor: 2.447

3.  The growth inhibitory effect of gambogic acid on pancreatic cancer cells.

Authors:  Mаhmoud Youns; Abeer ElKhoely; Rehab Kamel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-03-15       Impact factor: 3.000

Review 4.  Molecular targets of gambogic acid in cancer: recent trends and advancements.

Authors:  Dharambir Kashyap; Rajkumar Mondal; Hardeep Singh Tuli; Gaurav Kumar; Anil K Sharma
Journal:  Tumour Biol       Date:  2016-07-22

5.  Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer.

Authors:  Ravi Doddapaneni; Ketan Patel; Ibtisam Hasan Owaid; Mandip Singh
Journal:  Drug Deliv       Date:  2015-12-24       Impact factor: 6.419

Review 6.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

7.  Single-walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells.

Authors:  Lamya M Saeed; Meena Mahmood; Sebastian J Pyrek; Tariq Fahmi; Yang Xu; Thikra Mustafa; Zeid A Nima; Stacie M Bratton; Dan Casciano; Enkeleda Dervishi; Anna Radominska-Pandya; Alexandru S Biris
Journal:  J Appl Toxicol       Date:  2014-09-12       Impact factor: 3.446

8.  Development and validation of a luminescence-based, medium-throughput assay for drug screening in Schistosoma mansoni.

Authors:  Cristiana Lalli; Alessandra Guidi; Nadia Gennari; Sergio Altamura; Alberto Bresciani; Giovina Ruberti
Journal:  PLoS Negl Trop Dis       Date:  2015-01-30

9.  Oblongifolin C inhibits metastasis by up-regulating keratin 18 and tubulins.

Authors:  Xiaoyu Wang; Yuanzhi Lao; Naihan Xu; Zhichao Xi; Man Wu; Hua Wang; Xiyi Li; Hongsheng Tan; Menghong Sun; Hongxi Xu
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

10.  Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells.

Authors:  Fei Wang; Wei Zhang; Liting Guo; Wen Bao; Nan Jin; Ran Liu; Ping Liu; Yonghui Wang; Qinglong Guo; Baoan Chen
Journal:  Cancer Sci       Date:  2014-07-27       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.